Skip to main content

Table 6 In silico ADME of studied structures

From: Design, synthesis, biological assessments and computational studies of 3-substituted phenyl quinazolinone derivatives as promising anti-cancer agents

Entry

Absorption

Distribution

Compounds

%HIA

In vitro Caco-2 cell permeability (nm s−1)

In vitro skin permeability (LogKp, cm s−1)

% In vitro plasma protein binding

%BBB

7a

95.27

11.93

− 3.37

91.12

1.04

7b

95.28

12.84

− 3.65

86.49

1.03

7c

95.83

6.51

− 3.25

90.69

1.68

7d

92.87

15.49

− 4.25

97.91

1.15

7e

93.98

10.23

− 4.10

95.12

1.99

7f

96.63

25.13

− 3.28

100

0.136

7g

95.79

27.15

− 2.46

95.95

7.45

7h

95.88

27.99

− 2.43

94.96

7.86

7i

95.08

17.99

− 3.36

87.52

0.76

7j

95.10

19.09

− 3.63

84.72

0.73

7k

95.67

16.72

− 3.38

89.30

1.06

7l

88.83

18.97

− 4.30

97.20

1.06

7m

96.50

25.99

− 3.23

96.67

0.08

7n

95.73

25.62

− 2.43

93.34

5.83

7o

95.85

26.22

− 2.51

96.09

6.37